Omnigen Research, LLC
Records under this name other than the patents Omnigen Research, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,419,888 | Composition and Method for Promoting Reduction of Heat Stress in Animals Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,555,964 | Composition and Method for Promoting Reduction of Heat Stress in Animals Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,663,644 | Augmentation of Titer for Vaccination in Animals Term ended Term ended Apr 26, 2026 · High confidence | Term ended | Term ended Apr 26, 2026 | High confidence |
| US 8,828,402 | Augmentation of Titer for Vaccination in Animals Term ended Ended no later than Apr 26, 2026 · Low confidence | Term ended | Ended no later than Apr 26, 2026 | Low confidence |
| US 9,114,129 | Augmentation of Titer for Vaccination in Animals Term ended Ended no later than Apr 26, 2026 · Low confidence | Term ended | Ended no later than Apr 26, 2026 | Low confidence |
| US 8,236,303 | Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4) Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function Lapsed on the fee record Ended Aug 7, 2024 · High confidence | Lapsed on the fee record | Ended Aug 7, 2024 | High confidence |
| US 8,568,715 | Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function Term ended Term ended Apr 5, 2024 · High confidence | Term ended | Term ended Apr 5, 2024 | High confidence |
| US 8,834,868 | Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function Term ended Ended no later than Apr 5, 2024 · Medium confidence | Term ended | Ended no later than Apr 5, 2024 | Medium confidence |
| US 8,142,798 | Augmentation of Titer for Vaccination in Animals Lapsed on the fee record Ended Mar 27, 2024 · High confidence | Lapsed on the fee record | Ended Mar 27, 2024 | High confidence |
| US 9,173,926 | Use of BETA-1,3 (4)-Endoglucanohydrolase, BETA-1,3 (4)-Glucan, Diatomaceous Earth, Mineral Clay and Glucomannan to Augment Immune Function Lapsed on the fee record Ended Nov 3, 2023 · Medium confidence | Lapsed on the fee record | Ended Nov 3, 2023 | Medium confidence |